Valuation GI Innovation, Inc.

Stocks

End-of-day quote Korea S.E. 2026-08-28			5-day change	1st Jan Change
8,090.00 ^KRW	+0.87%		+6.03%	-54.14%

04-23	GI Innovation Enters Melanoma First-Line Treatment Market with GI-102 Approval for Phase 2 Clinical Trial Direct Comparison with Keytruda	CI
03-20	GI Innovation And Johnson & Johnson Enter Clinical Supply Agreement For Prostate Cancer Combination Therapy	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2023	2024	2025
Market Cap ¹	531,894	391,211	1,126,313
Change	-	-26.45%	187.9%
Enterprise Value (EV) ¹	490,884	387,772	1,091,686
Change	-	-21.01%	181.53%
P/E	-8.52x	-6.04x	-29.2x
PBR	7.42x	13.7x	9.67x
PEG	0.1x	-1.76x	0.5x
Capitalization / Revenue	100x	16,112x	193x
EV / Revenue	92.3x	15,970x	187x
EV / EBITDA	-9.82x	-8.59x	-29x
EV / EBIT	-9.21x	-8.04x	-26.9x
EV / FCF	-24.6x	-14.6x	-29.7x
FCF Yield	-4.07%	-6.87%	-3.37%
Dividend per Share ²	-	-	-
Rate of return	-	-	-
EPS ²	-1,286	-1,330	-604.4
Distribution rate	-	-	-
Net sales ¹	5,319	24.28	5,838
EBITDA ¹	-49,975	-45,159	-37,646
EBIT ¹	-53,305	-48,260	-40,635
Net income ¹	-55,495	-58,784	-35,135
Net Debt ¹	-41,010	-3,440	-34,627
Reference price ²	10,954.55	8,027.27	17,640.00
Nbr of stocks (in thousands)	48,555	48,735	63,850
Announcement Date	2/29/24	3/1/25	3/1/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GI INNOVATION, INC.	-	-	-	-	379M
LONZA GROUP AG	34.28x	6.11x	18.18x	0.94%	50.47B
REVOLUTION MEDICINES, INC.	-21.19x	258.61x	-22.63x	-.--%	44.56B
IQVIA HOLDINGS INC.	33.71x	3.27x	14.1x	-.--%	43.08B
BEONE MEDICINES AG	48.04x	5.57x	30.46x	-.--%	41.7B
CELLTRION, INC.	28.96x	8.75x	22.11x	0.4%	33.21B
MEDPACE HOLDINGS, INC.	34.16x	5.6x	25.43x	-.--%	16.77B
EUROFINS SCIENTIFIC SE	24.12x	2.1x	9.08x	1.12%	14.58B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	77.98x	4.1x	15.89x	-.--%	13.92B
Average	32.51x	36.76x	14.08x	0.31%	28.74B
Weighted average by Cap.	27.93x	49.08x	12.78x	0.3%